Filter posts

2012: A Critical Year for Biotechnology

In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce …

The Ethics of Global Clinical Trials

By Dr. Russell Medford, Salutria Pharmaceuticals Recent reports have raised concerns about how clinical trials are …

Medical Innovation at Risk

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists …

How to grow the economy and feed the world

By Barbara Wells, President and CEO, ArborGen Chair, BIO Food and Agriculture Section Governing Board …

How we are advancing American innovation to cure disease and save lives

Mankind’s need to cure disease, combat hunger and discover new forms of energy has never …

Biotech addresses food security, climate change: Potential economic growth engine

By Jose W. Fernandez, Assistant Secretary of State for Economic, Energy and Business Affairs By …

Biologics & Biosimilars: What is the Science Telling Us?

Panelists from the varied backgrounds of academia, business and regulation agreed on the highest scientific …

FDA: A Cornerstone of America’s Economic Future

By Nancy Bradish Myers, JD, President, Alliance for a Stronger FDA For close to 20 …

Biotechnology and the State of the Union Address

The following was published in Politico’s Join the Debate.  Politico asked “What should Obama say …